These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21044453)

  • 1. Use of methotrexate in inflammatory myopathies.
    Fendler C; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the inflammatory myopathies: update and practical recommendations.
    Hengstman GJ; van den Hoogen FH; van Engelen BG
    Expert Opin Pharmacother; 2009 May; 10(7):1183-90. PubMed ID: 19405792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory myopathies: how to treat the difficult cases.
    Mastaglia FL; Zilko PJ
    J Clin Neurosci; 2003 Jan; 10(1):99-101. PubMed ID: 12464534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.
    Dalakas MC
    Neuromuscul Disord; 2006 Apr; 16(4):223-36. PubMed ID: 16542836
    [No Abstract]   [Full Text] [Related]  

  • 19. Current diagnosis and treatment of polymyositis and dermatomyositis.
    Sasaki H; Kohsaka H
    Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-to-date treatment and management of myositis.
    Pipitone N; Salvarani C
    Curr Opin Rheumatol; 2020 Nov; 32(6):523-527. PubMed ID: 32890030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.